Cargando…
CC-223, NSC781406, and BGT226 Exerts a Cytotoxic Effect Against Pancreatic Cancer Cells via mTOR Signaling
The mTOR signaling pathway is abnormally activated in pancreatic cancer and is related to tumor glucose metabolism. However, its specific regulation mechanism is still unclear. Therefore, this study aims to investigate whether Sestrin2 affects the glucose metabolism of pancreatic cancer by modulatin...
Autores principales: | Guo, Yangyang, Zhu, Hengyue, Weng, Min, Zhang, Hewei, Wang, Cheng, Sun, Linxiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7741184/ https://www.ncbi.nlm.nih.gov/pubmed/33343350 http://dx.doi.org/10.3389/fphar.2020.580407 |
Ejemplares similares
-
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells
por: Simioni, Carolina, et al.
Publicado: (2015) -
Chemopreventive effect of Betulinic acid via mTOR -Caspases/Bcl2/Bax apoptotic signaling in pancreatic cancer
por: Guo, Yangyang, et al.
Publicado: (2020) -
Correction to: Chemopreventive effect of Betulinic acid via mTOR -Caspases/Bcl2/Bax apoptotic signaling in pancreatic cancer
por: Guo, Yangyang, et al.
Publicado: (2021) -
Baohuoside I via mTOR Apoptotic Signaling to Inhibit Glioma Cell Growth
por: Guo, Yangyang, et al.
Publicado: (2020) -
The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolism
por: Zhu, Hengyue, et al.
Publicado: (2021)